Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential.
De La Cruz, Lucy M
Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential. [electronic resource] - Immunotherapy 10 2016 - 1219-32 p. digital
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1750-7448
10.2217/imt-2016-0052 doi
Breast Neoplasms--immunology
Cancer Vaccines--immunology
Dendritic Cells--immunology
Female
Humans
Immunotherapy--methods
Lymphocyte Activation
Neoadjuvant Therapy
Receptor, ErbB-2--immunology
Survival Analysis
Th1 Cells--immunology
Trastuzumab--therapeutic use
Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential. [electronic resource] - Immunotherapy 10 2016 - 1219-32 p. digital
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1750-7448
10.2217/imt-2016-0052 doi
Breast Neoplasms--immunology
Cancer Vaccines--immunology
Dendritic Cells--immunology
Female
Humans
Immunotherapy--methods
Lymphocyte Activation
Neoadjuvant Therapy
Receptor, ErbB-2--immunology
Survival Analysis
Th1 Cells--immunology
Trastuzumab--therapeutic use